Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. (SNOA) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 69 transactions totaling $125.4K, demonstrating a bullish sentiment with $125.4K in net insider flow. The most recent transaction on Jun 20, 2024 involved a transaction of 15,000 shares valued at $0.
SNOA Insider Activity Summary
Who Is Buying SNOA Stock?
No significant insider buying has been recorded for SNOA in the recent period.
Who Is Selling SNOA Stock?
No significant insider selling has been recorded for SNOA in the recent period.
Is Sonoma Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SNOA is bullish with an Insider Alignment Score of 100/100 and a net flow of $125.4K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
SNOA Frequently Asked Questions
Understanding SNOA Insider Activity
Insider trading at Sonoma Pharmaceuticals, Inc. (SNOA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading SNOA stock, having executed 69 transactions in the past 90 days. The most active insider is Robert E. Miller (Executive), who has made 16 transactions totaling $86.8K.
Related Tools
Track Sonoma Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SNOA file new Form 4 transactions